425: Strive-Semler Merger: Risks & Forward-Looking Statements

Strive, Inc. filed a Form 425 regarding its proposed business combination with Semler Scientific, Inc., highlighting associated risks and forward-looking statements.

Summary

• A communication was posted on X.com by Ben Werkman, Chief Investment Officer of Strive, Inc., on November 10, 2025.
• The communication is in connection with Strive's proposed business combination with Semler Scientific, Inc.
• It serves as a cautionary statement regarding forward-looking statements, emphasizing inherent risks and uncertainties.
• Actual results could differ materially from anticipated results due to various factors.
• Investors and stockholders are urged to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus when they become available for important information.

Sentiment

Score: 4

Explanation: The document is primarily a cautionary statement regarding a proposed business combination, heavily emphasizing risks and uncertainties associated with forward-looking statements. While it mentions potential benefits, the overwhelming focus is on potential negative outcomes and factors that could cause actual results to differ materially, leading to a cautious to slightly negative sentiment.

Positives

• The proposed transaction is expected to yield strategic benefits and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are expected from the business combination.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both parties to terminate the merger agreement.
• The proposed transaction may not close when expected or at all because closing conditions are not received or satisfied on a timely basis.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks related to Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, laws, and regulations and their enforcement.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing outlines expectations regarding the proposed transaction, including strategic and financial benefits, the timing of closing, and the ability to successfully integrate the combined businesses, while emphasizing these are forward-looking statements subject to significant risks and uncertainties.

Management Comments

• Communication posted on X.com by Ben Werkman, Chief Investment Officer of Strive, Inc., on November 10, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' indicates Strive's or the combined entity's involvement in or exposure to the evolving digital asset landscape, a significant trend in corporate finance and investment strategies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement in connection with its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Potential adverse reactions of Strive's or Semler Scientific's customers.
• Changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Dilution for Strive's Class A common stockholders due to the issuance of additional shares.

Next Steps

• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• The proposed transaction will close, subject to conditions being received or satisfied.

Key Dates

Recommendation

This filing is a procedural document primarily focused on outlining the significant risks and uncertainties associated with the proposed business combination between Strive and Semler Scientific. While it alludes to potential strategic and financial benefits, it provides no new financial performance data or definitive positive catalysts. The extensive list of risks, including integration challenges, market conditions, and potential dilution, warrants a cautious stance. Investors should hold their positions and await the definitive Information Statement/Proxy Statement/Prospectus and further clarity on the transaction's progress and financial implications before making any significant investment decisions.

Keywords

Business combination, Merger, Acquisition, SEC filing, Form 425, Strive Inc, Semler Scientific Inc, Forward-looking statements, Risk factors, Corporate governance, Bitcoin treasury, Digital assets